Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
R. Asciak (Oxford, United Kingdom), N. Kanellakis (Oxford, United Kingdom), A. Kidd (Glasgow, United Kingdom), A. Bibby (Bristol, United Kingdom), N. Maskell (Bristol, United Kingdom), K. Blyth (Glasgow, United Kingdom), R. Mercer (Oxford, United Kingdom), P. Fsadni (Msida, Malta), S. Montefort (Msida, Malta), I. Psallidas (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom). The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients. 4492

Member's Comments

No comment yet.

Related content which might interest you:

• Massive pleural effusion presented with a very rare multitude of complication
• Malignant pleural effusion management: is combining pleurodesis techniques the way forward? Results of the IPC-PLUS trial.
• TIME for a change in practice: insights from the TIME 1, 2, and 3 trials